| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Sales - EUR | - | - | - | - | 1.304 | 19.163 | 29.357 | 55.305 | 62.825 | 65.808 |
| Total Income - EUR | - | - | - | - | 1.304 | 19.163 | 29.357 | 55.305 | 62.825 | 65.808 |
| Total Expenses - EUR | - | - | - | - | 61 | 767 | 132 | 621 | 8.458 | 9.872 |
| Gross Profit/Loss - EUR | - | - | - | - | 1.243 | 18.396 | 29.225 | 54.685 | 54.367 | 55.936 |
| Net Profit/Loss - EUR | - | - | - | - | 1.204 | 17.860 | 28.344 | 53.237 | 53.752 | 53.962 |
| Employees | - | - | - | - | 0 | 0 | 0 | 1 | 2 | 1 |
Check the financial reports for the company - Laur Cardiodoc S.r.l.
| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Fixed Assets | - | - | - | - | 0 | 0 | 0 | 0 | 0 | 0 |
| Current Assets | - | - | - | - | 1.285 | 18.379 | 36.299 | 61.576 | 63.490 | 64.616 |
| Inventories | - | - | - | - | 0 | 0 | 0 | 0 | 0 | 0 |
| Receivables | - | - | - | - | 0 | 1.786 | 0 | 44.811 | 40.028 | 36.588 |
| Cash | - | - | - | - | 1.285 | 16.593 | 36.299 | 16.765 | 23.462 | 28.028 |
| Shareholders Funds | - | - | - | - | 1.246 | 18.194 | 36.026 | 60.986 | 61.990 | 62.171 |
| Social Capital | - | - | - | - | 42 | 41 | 40 | 41 | 40 | 40 |
| Debts | - | - | - | - | 39 | 185 | 272 | 590 | 1.500 | 2.445 |
| Income in Advance | - | - | - | - | 0 | 0 | 0 | 0 | 0 | 0 |
| Exchange rate - RON | 4.9743 | 4.9465 | 4.9315 | 4.9468 | 4.8371 | 4.7454 | 4.6535 | 4.5681 | 4.4908 | 4.445 |
| Main CAEN | "8622 - 8622" | |||||||||
| CAEN Financial Year |
8622
|
|||||||||
Comments - Laur Cardiodoc S.r.l.